Osteopore (ASX:OSX) secured an exclusive two-year agreement with Peakmed for its craniofacial implant products in Thailand, according to a Tuesday filing with the Australian bourse.

Peakmed specializes in the distribution of surgical instruments and implants across craniomaxillofacial applications and has a distribution network of 70 hospitals across Thailand.

Osteopore's neurosurgical implants are focused on treating a range of brain surgeries where bone tissue is removed, such as burr hole and craniotomy procedures.

Its shares fell 6% on market close.